Inflazome raises 40 mln euros

Forbion said Nov. 19 that it led a 40 million euros ($46 million) financing round for Inflazome. Longitude Capital and founding investors, Novartis Venture Fund, and Fountain Healthcare Partners also participated in the round. Inflazome, of Dublin, Ireland, is developing small molecule drugs that block harmful inflammation.

North AmericaUSBriefs